Upload
hairul-anuar
View
214
Download
0
Embed Size (px)
Citation preview
8/3/2019 Antibiotic Module
1/49
8/3/2019 Antibiotic Module
2/49
Objectives
1. Enumerate Principles of antimicrobial
therapy
2. Verify Choice of the antimicrobial agents
3. State Misuse of antibiotics
4. Mention Causes of failure of antimicrobial
therapy5. Classify antimicrobial drugs
8/3/2019 Antibiotic Module
3/49
Principles of antimicrobial
therapy
8/3/2019 Antibiotic Module
4/49
8/3/2019 Antibiotic Module
5/49
What are the principles of antimicrobial therapy ?
Appropriate indication
Appropriate dosage
Suitable length of treatment period
When to start treatment
Target of therapy (prophylaxis or treatment).
Good knowledge of the drug's pharmacokinetics and
potential risk.
Combination only under certain conditions and rightchoice of combination.
5
8/3/2019 Antibiotic Module
6/49
When do you start the treatment?
Ideally
when the organism is identified and its drug
susceptibility established
However,acutely ill patients usually require
immediate treatment
Empiric therapy :Therapy is initiated afterspecimens for laboratory analysis have beenobtained but before the results of the culture are
available.
8/3/2019 Antibiotic Module
7/49
What are the purposes for use of
antibiotics ? (Aim of therapy )
Prophylaxis A Medical:
- Exposure to virulent pathogen (HIV, N. meningitis)
- Immunocompromised Bsurgical
- To prevent wound infections after surgical procedures.
To prevent Endocarditis inpatients with valvular heart disease undergoing
dental or other surgeries producing bacteremia. Empiric Therapy (usually up to 72 hours)
Definitive Therapy
7
8/3/2019 Antibiotic Module
8/49
Combinations Of Antimicrobial Drugs
8
8/3/2019 Antibiotic Module
9/49
Combinations Of Antimicrobial Drugs
Indication:1. Empiric therapy of severe infection in which cause is
unknown(unknown etiology)
2. In mixed infections(polymicrobial infections),e.g. intra-abdominalinfections.
3. To delay emergence of resistant strains
4. To enhance antimicrobial activity , i.e. achieve an effect notobtained by either alone(e.g. combinations of penicillin and
aminoglycoside antibiotics are effective against enterococci,whereas neither agent alone is bactericidal againstenterococci).
5. To reduce the incidence and intensity of adverse reactions.
9
8/3/2019 Antibiotic Module
10/49
Antibiotic combination therapy:
Synergistic Effect: when the effects of a combination of antibiotics
is greater than the sum of the effects of the individual antibiotics.When two bactericidal antibiotics are used in combination (e.g.
penicillin + streptomycin)
Additive Effect:When two bacteriostatic agents with the same mechanisms
of action are used.
Antagonism: occurs when one antibiotic, interferes with the effects
of another antibiotic. Usually bacteriostatic antibiotics are
antagonistic to bactericidal agents.
(e.g. Chloramphenicol + penicillin)
8/3/2019 Antibiotic Module
11/49
Choice of the antimicrobial
agents
8/3/2019 Antibiotic Module
12/49
Choice of The Antimicrobial Agent
A- Factors related to drug:
Antibiotic spectrum and activity.
The minimal inhibitory concentration (MIC)
compared to concentration achieved at site of
infection
known risk of the antibiotic, like nephrotoxicity
with aminoglycosides Possibility of developing resistance.
Drug's phamacokinetic parameters: absorption,
distribution and clearance.
8/3/2019 Antibiotic Module
13/49
Spectrum of Activity
Refers to the range of microorganisms that anantimicrobial agent can kill or inhibit
Broad spectrum
affect a wide range of bacteria used particularly in the cases of rapid onset life-
threatening infections, when there is no time to culture
the causative agent
can disrupt the normal flora of the body leading tosuperinfection.
Narrow spectrum
Affect a limited range of bacteria
requires the identification of the pathogen
8/3/2019 Antibiotic Module
14/49
Antibiotic activity
Bacteriostatic - arrest the growth and replication of bacteria
at serum levels achievable in the patient .
They reversibly inhibit the growth of bacteria .They limit the
spread of infection while the body's immune system attacks,
immobilizes, and eliminates the pathogens.
If the drug is removed before the immune system has
scavenged the organisms, enough viable organisms may
remain to begin a 2nd cycle of infection. Therefore must be
given for enough duration of time.
If possible, bactericidal antibiotics should be used to treat
infections of the endocardium or the meninges. Host
defenses are relatively ineffective at these sites and the
dangers imposed by such infections require prompteradication of the organisms.
8/3/2019 Antibiotic Module
15/49
Bactericidal - kill bacteria at drug serum levels
achievable in the patient. - often drugs of
choice in seriously ill patients.
8/3/2019 Antibiotic Module
16/49
Concentration of antibiotic
Minimum inhibitory concentration (MIC):
The lowest concentration of AB that inhibits bacterial
growth after overnight incubation.
Minimum bactericidal concentration (MBC):
The lowest concentration of AB that results in a 99.9
percent decline in colony count after overnight incubation.
8/3/2019 Antibiotic Module
17/49
Drug resistance
Bacteria are said to be resistant to an
antibiotic if their growth is not halted by the
maximal level of that antibiotic that can be
tolerated by the host
8/3/2019 Antibiotic Module
18/49
Choice of The Antimicrobial Agent
B- Factors related to host1. Host's defense mechanisms
2. Host's clinical conditions
3. Local factors
4. Age
5. Genetic factors
6. Pregnancy and lactation
7. Drug allergy
8/3/2019 Antibiotic Module
19/49
1. Host's defense mechanisms
Immune system:
The host defense system must eliminate invading
organisms.
Alcoholism, diabetes, immunodeficiency virus,
malnutrition, advanced age affect a patient'simmunocompetency.
if host defense are impaired in these individuals:
A bactericidalATB must be used : Higher-than-usual doses of
bactericidal ATB or longer courses of treatment .
8/3/2019 Antibiotic Module
20/49
2. Host's clinical conditions
Renal dysfunction:
Poor kidney function (10 % or less of normal) - accumulation of ATB
(eliminated by kidney) - serious adverse effects adjust the dose of
ATB eliminated by the kidney and avoid nephrotoxic ABTs.
Hepatic dysfunction:
ATB concentrated or eliminated by the liver (e.g., erythromycin and
tetracycline) are contraindicated in liver disease.
8/3/2019 Antibiotic Module
21/49
3-Local Factors
Access of antibiotic to sites of infection e.g.if the infection in the CSF the drug must pass
the blood brain barrier
Penetration of antibiotic into infected areassuch abscess is impaired because vascular
supply is reduced &antimicrobial activity may
be significantly reduced in pus. Presence of the foreign bodies reduces the
effectiveness of antibiotic.
8/3/2019 Antibiotic Module
22/49
4-Age
Elderly patients - particularly vulnerable toaccumulation of drugs eliminated by the kidneys. The
number of functioning nephrons decreases with age.
Young children -Renal or hepatic elimination - oftenpoorly developed in newborns
Also newborns are particularly vulnerable to certain
antibiotics.
8/3/2019 Antibiotic Module
23/49
5- Genetic Factors
A number of drugs (e.g. sulfonamides,
chloramphenicol) may produce acute
hemolysis in patient with glucose 6-phosphate dehydrogenase deficiency
8/3/2019 Antibiotic Module
24/49
6- Pregnancy
Pregnancy may impose an increased risk of
reaction to antibiotic for both mother & fetus
Hearing loss in child with administration of
streptomycin to the mother during pregnancy
Tetracycline can affect bones & teeth of fetus .
8/3/2019 Antibiotic Module
25/49
7- Drug allergy
-lactum ABTs e may provoke allergic reaction
Sulfonamides and erythromycin have been
associated with hypersentitivity reaction
8/3/2019 Antibiotic Module
26/49
What are the causes of Misuse of
antibiotics?
Treatment of untreatable infection
Treatment of fever of undetermined origin
Improper dose
Reliance on chemotherapy with omission of
surgical drainage of purulent exudates or
necrotic tissue
Lack of adequate bacteriological information
26
8/3/2019 Antibiotic Module
27/49
Causes of Failure of
Antimicrobial Treatment
8/3/2019 Antibiotic Module
28/49
Causes of Failure of Antimicrobial
Treatment
Incorrect indication
Ineffective antibiotic Inapproapirate dosage
Inadequate duration
Development of resistance
Change of causative pathogens
8/3/2019 Antibiotic Module
29/49
Classify Antibiotics
Classification of Antibiotics according:
Chemical Structure
Spectrum of Activity& effects Mechanism of Action
29
8/3/2019 Antibiotic Module
30/49
Classify Antibiotics
Spectrum of Antibiotic activity
Narrow spectrum Antibiotic
Broad spectrum Antibiotic
Effects of Antibiotics
Bacteriostatic
Bacteriocidal
8/3/2019 Antibiotic Module
31/49
Classification of some antibacterial agents by their sites of action
THFA = tetrahydrofolic acid; PABA = p-aminobenzoic acid
CELL WALLCELL MEMBRANE
DNA
THFA
PABARibosomes mRNA
Inhibitors of cellmembranefunction
IsoniazidAmphotericin B
Inhibitors ofnucleic acidfunction orsynthesis
FluoroquinolonesRifampin
Inhibitors ofmetabolism
SulfonamidesTrimethoprim
Inhibitors of cellwall synthesis
b-LactamsVancomycin
Inhibitors ofprotein synthesis
TetracyclinesAminoglycosidesMacrolidesClindamycinChloramphenicol
8/3/2019 Antibiotic Module
32/49
Cell wall synthesis inhibitors
Summary of anti microbial agents affecting cell wall
8/3/2019 Antibiotic Module
33/49
Summary of antimicrobial agents affecting cell wallsynthesis
INHIBITORS OF CELLWALL SYNTHESIS b-LACTAMASE
INHIBITORS
b-LACTAMANTIBIOTIC
OTHERANTIBIOTIC
PENICILLINS CEPHALOSPORINS CARBAPENEMS MONOBACTAMS
1st GENERATION 2nd GENERATION 3rd GENERATION 4th GENERATION
Clavulanic acidSulbactamTazobactam
BacitracinVancomycin
Imipenem/cilastatinMeropenem*Ertapenem
Aztreonam
Cefepime
AmoxicillinAmpicillinCloxacillinDicloxacillinIndanyl carbenicillinMethicillin
NafcillinOxacillinPenicillin GPenicillin VPiperacillinTicarcillin
CefadroxilCefazolinCephalexinCephalothin
CefaclorCefamandoleCefprozilCefuroximeCefotetanCefoxitin
CefdinirCefiximeCefoperazoneCefotaximeCeftazidimeCeftibutenCeftizoximeCeftriaxone
8/3/2019 Antibiotic Module
34/49
The Beta-lactams
Beta-lactams are a broad class of antibioticsthat have in common a four membered beta-
lactam ring structure. They include:
1. Penicillins,
2. Cephalosporins,
3. Carbapenems,
4. Monobactam
34
8/3/2019 Antibiotic Module
35/49
b-lactam Antibiotics
35
Monobactams
All of the drugs in this group containa -lactam ring in their structure
Penicillins
NO
S
Carbapenems
NO
NO
NO
S
Cephalosporins
Share similar features of chemistry,
mechanism of action Cross reactivity
Bacteria might develop resistance to
-lactam antibiotics by synthesizingbeta lactamase, an enzyme that
attacks the-lactam ring.
8/3/2019 Antibiotic Module
36/49
What is the mechanism of action of
penicillin ?
Penicillins enter the bacteria via the cell wall
Inside the cell, they bind to penicillin-binding protein
Once bound, normal cell wall synthesis is disrupted
Result: bacteria cells die from cell lyses
Penicillins do not kill other cells in the body
36
8/3/2019 Antibiotic Module
37/49
Penicillin Groups1. Penicillin G ( -Lactamase sensitive)
2. Depot preparations: (long actin preparations) ( -Lactamase sensitive)
3. Acid resistant penicillins (penicillin V) ( -Lactamase
sensitive).
4. -Lactamase -resistant penicillins (anti-
staphylococcal penicillins). 1,2 ,3 & 4 are narrow
spectrum
5. Broad spectrum penicillins ( -Lactamase sensitive)6. Antipseudomonal penicillins (extended spectrum
penicillin) ( -Lactamase sensitive)
8/3/2019 Antibiotic Module
38/49
1- Penicillins G
Pharmacokinetics Penicillin G is rapidly hydrolyzed by gastric acidity, so it is
not given orally but only parenterally
There is poor penetration into CSF, unless inflammation is
present. Active renal tubular secretion results in a short half-life.
counteracted by
- Giving high doses
- Simultaneous administration of probencid
- Using the depot preparations
38
8/3/2019 Antibiotic Module
39/49
What are the disadvantages of
Penicillins G?
1. Short duration of action.
2. Instability in acidic medium.
3. Destroyed by b-Lactamase enzymes.
4. Possess a narrow spectrum of activity(active
against some gram +ve and gramve ) .
8/3/2019 Antibiotic Module
40/49
2- Depot preparations:(long actin preparations)
penicillin Gprocaine(used every 18-24 hours)
penicillin G benzathine (duration ofantimicrobial activity in the plasma is up to
one month) Such agents release penicillin G slowly from
the area in which they are injected andproduce relatively low but persistentconcentrations of antibiotic in the blood.
8/3/2019 Antibiotic Module
41/49
3-Acid-stable Penicillins- penicillin V
- Theoralform of penicillins
- Indicated only in minor infections because of:
1. Poor bioavailability.
2. Frequent dosing 4-6 times per day.3. Narrow spectrum of activity.
4. -Lactamase sensitivity.
5. Cant be used for treatment of bacteraemia
because of high lethal dose needed.
41
4 Lactamase resistant penicillins
8/3/2019 Antibiotic Module
42/49
4- -Lactamase -resistant penicillins
(Anti-staphylococcal penicillins)
Nafcillin,(I.V)
Dicloxacillin (oral)
These antibiotics are most useful against infections
caused by -Lactamase -producing staphylococci.
Nafcillin is excreted in bile.
42
d i illi
8/3/2019 Antibiotic Module
43/49
5- Broad spectrum penicillins(Aminopenicillins) (ampicillin, amoxicillin)
- Developed to increase activity against gram-negative aerobes, including some strains of E.coli, Klebsiella, and Haemophilus. But not activeagainst Pseudomonas.
- Broad-spectrum penicillin but beta lactamasesensitive.
- Amoxicillin is often combined with clavulanate(b
lactamae inhibitor), and this combination can be
used for beta-lactamases producing organisms.
6 Antipseudomonal penicilins
8/3/2019 Antibiotic Module
44/49
6- Antipseudomonal penicilins
Ticarcillin
These agents have similar spectrums of activity as the
aminopenicillins but with additional activity against
several gram negative organisms including many
strains of Pseudomonas aeruginosa. Like the
aminopenicillins, these agents are susceptible to
inactivation by beta-lactamases.
Chiefly used to treat serious infections caused by G-ve
microorganisms, particular P.aeruginosa
44
8/3/2019 Antibiotic Module
45/49
8/3/2019 Antibiotic Module
46/49
Penicillin-beta-lactamase inhibitor
combination
Combination drugs:
Ampicillin + Sulbactam = Unasyn
Amoxicillin + Clavulanic acid = Augmentin
8/3/2019 Antibiotic Module
47/49
Penicillins: Therapeutic uses
1. Meningitis,
2. Bacterial pneumonia,
3. Streptococcal infections,
4. Syphilis,
5. Prophylactic against:
Gonococcal infection Recurrence of rheumatic fever.
8/3/2019 Antibiotic Module
48/49
Penicillins: side effects
Hypersensitivity
skin rashes, fever, and anaphylactic shock.
Cross-reactivity exists among all penicillins andeven otherb-lactams
Because the penicillins(especially broad
spectrum penicillins) may alter gut flora,antibiotic-associated diarrhea can occur, as
well as selecting out resistant bacteria in the
colon (superinfections).48
8/3/2019 Antibiotic Module
49/49